D. Askin

927 citations
22 papers · 738 indexed · h-index 13

D. Askin

21 papers receiving 687 citations

Peers

D. Askin
Comparison fields: 5 of 76
  • Organic Chemistry 488
  • Toxicology 29
  • Inorganic Chemistry 83
  • Biotechnology 50
  • Molecular Biology 357
Replace Anna M. Costa with:
Anna M. Costa Spain
Elie Abushanab United States
Damoder Reddy Motati India
Ru-Ping Wang China
Suellen M. T. Cavalcanti Brazil
David S. Millan United Kingdom
Abraham Thomas India
Norihiro Ikemoto United States
Braja G. Hazra India
Naganna M. Goudgaon United States
D. Askin relative to Anna M. Costa Spain Anna M. Costa's profile →
Citations per field
00.5×3.6×
Anna M. Costa · 1×
Citations per year

Countries citing papers authored by D. Askin

Since Specialization
Citations

This map shows the geographic impact of D. Askin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Askin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Askin more than expected).

Fields of papers citing papers by D. Askin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Askin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Askin. The network helps show where D. Askin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D. Askin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. Askin Line = papers co-authored together D. Askin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20252
2 20227
3
The Patient's Second Hip Fracture - One in Ten.
20203
4 19981
5
The synthesis of indinavir and other clinically useful HIV-1 protease inhibitors.
19985
6 199624
7 199538
8 199598
9 199544
10 199349
11 19923
12 1992173
13 19912
14 199139
15 199013
16 198935
17 1989116
18 198923
19 198823
20 198828

About D. Askin

D. Askin is a scholar working on Organic Chemistry, Orthopedics and Sports Medicine and Infectious Diseases, having authored 22 papers that have together received 738 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (6 papers), HIV/AIDS drug development and treatment (4 papers), Synthetic Organic Chemistry Methods (3 papers), Asymmetric Synthesis and Catalysis (3 papers), Chemical Synthesis and Reactions (3 papers), Oxidative Organic Chemistry Reactions (3 papers), Synthesis and Catalytic Reactions (2 papers) and Hip and Femur Fractures (2 papers). The work is most often cited by research in Organic Chemistry (488 citations), Toxicology (29 citations) and Inorganic Chemistry (83 citations). D. Askin has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Robert A. Reamer, R. P. Volante, I. Shinkai, M A Wallace, Joseph P. Vacca, Todd K. Jones, Kai Rossen, Paul J. Reider, Sander G. Mills and Richard Desmond. Their work appears in journals such as Tetrahedron Letters, The Journal of Organic Chemistry, Journal of the American Chemical Society, Tetrahedron and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026